1. Home
  2. |Insights
  3. |ACI's Maximizing Pharmaceutical Patent Lifecycles

ACI's Maximizing Pharmaceutical Patent Lifecycles

Event | 10.07.09 - 10.08.09, 12:00 AM UTC - 12:00 AM UTC

The Pharmaceutical Patent Endgame is in the midst of a radical metamorphoses being shaped by forces here and abroad.

A new pharmaceutical patent paradigm is emerging.

Be part of the one event which for nearly a decade has shaped industry policies and patent strategies for both brand name and generic drug companies.

This 10th American Conference Institute event on Maximizing Pharmaceutical Patent Life Cycles will bring you the thoughtful and targeted commentary and in-depth analysis that you have come to expect from this industry leading conference. This year’s conference will help you prepare for the sweeping changes currently underway.

Teresa Rea is the Moderator of a segment entitled "Patents, Pharmaceuticals and Political Considerations: Patent Reform and the Pharmaceutical Industry: Anticipating and Adapting to Change."

Insights

Event | 12.04.25

ACI 30th Annual Conference on Drug & Medical Device Litigation

Dan Campbell with Speak on the panel "Mastering MDL Case Management: What Proposed Rule 16.1 Really Means for Consolidated Litigation."
Rule 16.1 attempts to guide early case management in MDLs, impacting litigation pace and costs. Permissive language like “should” instead of “must”, could lead to inconsistent applications. This panel will explore the rule’s anticipated impact and implications for procedures.